JonesTrading analyst Soumit Roy reiterated a Buy rating on Mirati Therapeutics (MRTX – Research Report) today. The company’s shares closed
Category: Healthcare
Chimerix (CMRX) Receives a Hold from Cowen & Co.
In a report released today, Phil Nadeau from Cowen & Co. maintained a Hold rating on Chimerix (CMRX – Research
IMV (IMV) Received its Third Buy in a Row
After BTIG and Oppenheimer gave IMV (NASDAQ: IMV) a Buy rating last month, the company received another Buy, this time
Unity Biotechnology (UBX) Gets a Buy Rating from Mizuho Securities
Mizuho Securities analyst Salim Syed maintained a Buy rating on Unity Biotechnology (UBX – Research Report) today and set a
Intersect ENT (XENT) Gets a Hold Rating from BTIG
In a report released yesterday, Ryan Zimmerman from BTIG maintained a Hold rating on Intersect ENT (XENT – Research Report).
AxoGen (AXGN) Receives a Buy from BTIG
In a report released yesterday, Ryan Zimmerman from BTIG maintained a Buy rating on AxoGen (AXGN – Research Report), with
Analysts Have Conflicting Sentiments on These Healthcare Companies: Clovis Oncology (NASDAQ: CLVS), Orthofix (NASDAQ: OFIX) and Antibe Therapeutics (Other OTC: ATBPF)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Clovis Oncology (CLVS – Research